Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Celularity Inc NK Cell Therapy CYNK-001 Receives US FDA Fast Track Designation for AML Treatment

December 28, 2021 0

Celularity Inc Celularity Inc. (CELU) announced the U.S. Food and Drug Administration (FDA) has granted Fast …

Important and Encouraging News from Sutro Biopharma Inc

December 27, 2021 0

Sutro Biopharma Inc and Tasly Biopharmaceuticals Exclusive Licensing Agreement for STRO-002 In a press release from …

The FDA Authorized Emergency Use of Pfizer Paxlovid Pills Against COVID-19

December 25, 2021 0

Pfizer Received Emergency Use Authorization from the FDA for Paxlovid Pills for COVID-19 Good news for …

Comprehensive Prohost Letter #448

December 22, 2021 0

Comprehensive Prohost Letter Issues Coronavirus Variant Omicron A lot has happened since the coronavirus variant Omicron …

Gilead Sciences and Arcus Biosciences: Complete Closing of Option Exercises of 3 Programs. See Also: HOLD Put on Lenacapavir Due to Vial Quality Concern

December 22, 2021 0

Gilead Sciences and Arcus Biosciences Gilead Sciences (GILD) and Arcus Biosciences (RCUS) announced the closing of …

The FDA Cleared the IND for Erasca Inc Product ERAS-801 for Recurrent Glioblastoma

December 17, 2021 0

Erasca Inc Product ERAS-801 IND Cleared by FDA Erasca Inc (ERAS) announced that the United States Food and …

Arcturus Therapeutics Additional Updates from ARCT-154 and ARCT-165 Clinical Trials and More

December 16, 2021 0

Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings (ARCT) is a clinical-stage mRNA medicines company of enabling technologies with …

Devastated and Resurrected Good Biotech Firms: Theravance Biopharma

December 15, 2021 0

The Market Devastation and Resurrection of Good Biotech Firms Due to the market’s instability that we …

AstraZeneca Granted FDA EUA for Long Acting Antibody Evusheld for Pre-Exposure Prophylaxis of Covid-19

December 9, 2021 0

AstraZeneca Long Acting Antibody Granted FDA EUA for COVID-19 Prevention AstraZeneca (AZN) product Evusheld (tixagevimab co-packaged …

Ionis Pharmaceuticals to Collaborate with AstraZeneca in Treating Transthyretin Amyloidosis with Ionis Product Eplontersen

December 8, 2021 0

Ionis Pharmaceuticals and AstraZeneca in Collaboration to Treat ATTR with Eplontersen Ionis Pharmaceuticals (IONS) announced entering into …

Celldex Therapeutics Dosed the First Patient in a Phase 1 Study of CDX-0159 for Prurigo Nodularis

December 8, 2021 0

Celldex Therapeutics Dosed the First Patient with CDX-0159 for Prurigo Nodularis Celldex Therapeutics (CLDX) announced that …

Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron Variant

December 7, 2021 0

GlaxoSmithKline and Vir Biotechnology Sotrovimab Retains In Vitro Activity Against Omicron GlaxoSmithKline plc (GSK) and Vir Biotechnology …

Amgen: Positive Results from Otezla® Phase 3 DISCREET Study in Moderate to Severe Genital Psoriasis

December 2, 2021 0

Amgen Announces Positive Results from Otezla Study for Psoriasis Amgen (AMGN) announced positive top-line results from the …

Great News: Vertex Pharmaceuticals Announced Successful Phase 2 Study Results of VX-147

December 1, 2021 0

Vertex Pharmaceuticals Phase 2 Results of VX-147 Vertex Pharmaceuticals (VRTX) announced today that, in a Phase …

The Omicron Variant and the Bizarre Stock Market Chaos

November 30, 2021 0

The Bizarre Assessment of Biotech Firms in the Stock Market The Clinical-Stage Biotechnology Firms We are …

Ionis Pharmaceuticals Announces that Pfizer Reported Positive Results of Vupanorsen for Cardiovascular Risk Reduction and Severe Hypertriglyceridemia

November 25, 2021 0

Ionis Pharmaceuticals Announced Pfizer Update of Vupanorsen Ionis Pharmaceuticals (IONS) announced that Pfizer's (

Takeda Pharmaceutical Product LIVTENCITY Granted Approval by the FDA

November 25, 2021 0

Takeda Pharmaceutical Granted FDA Approval for LIVTENCITY for Post-Transplant Cytomegalovirus On November 23, 2021 Takeda Pharmaceutical …

The FDA Granted Orphan Drug Designation to Regenxbio Investigational Gene Therapy Drug RGX-202 for Duchenne Muscular Dystrophy

November 23, 2021 0

Regenxbio Granted Orphan Drug Designation for RGX-202 Regenxbio (RGNX) announced the U.S. FDA granted Orphan Drug …

Let’s Talk About 3 Firms with Important News: Cassava Sciences, Vertex Pharmaceuticals and Gilead Sciences

November 19, 2021 0

Cassava Sciences, Vertex Pharmaceuticals and Gilead Sciences All Have Good News Cassava Sciences & Alzheimer's Disease …

Arcus Biosciences Stock Price Skyrockets Following Gilead Sciences Decision to Augment Their Partnership

November 18, 2021 0

Gilead Sciences Collaboration with Arcus Biosciences Sends Stock Through the Roof There is no doubt that …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Celularity Inc NK Cell Therapy CYNK-001 Receives US FDA Fast Track Designation for AML Treatment

Important and Encouraging News from Sutro Biopharma Inc

The FDA Authorized Emergency Use of Pfizer Paxlovid Pills Against COVID-19

Comprehensive Prohost Letter #448

Gilead Sciences and Arcus Biosciences: Complete Closing of Option Exercises of 3 Programs. See Also: HOLD Put on Lenacapavir Due to Vial Quality Concern

The FDA Cleared the IND for Erasca Inc Product ERAS-801 for Recurrent Glioblastoma

Arcturus Therapeutics Additional Updates from ARCT-154 and ARCT-165 Clinical Trials and More

Devastated and Resurrected Good Biotech Firms: Theravance Biopharma

AstraZeneca Granted FDA EUA for Long Acting Antibody Evusheld for Pre-Exposure Prophylaxis of Covid-19

Ionis Pharmaceuticals to Collaborate with AstraZeneca in Treating Transthyretin Amyloidosis with Ionis Product Eplontersen

Celldex Therapeutics Dosed the First Patient in a Phase 1 Study of CDX-0159 for Prurigo Nodularis

Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron Variant

Amgen: Positive Results from Otezla® Phase 3 DISCREET Study in Moderate to Severe Genital Psoriasis

Great News: Vertex Pharmaceuticals Announced Successful Phase 2 Study Results of VX-147

The Omicron Variant and the Bizarre Stock Market Chaos

Ionis Pharmaceuticals Announces that Pfizer Reported Positive Results of Vupanorsen for Cardiovascular Risk Reduction and Severe Hypertriglyceridemia

Takeda Pharmaceutical Product LIVTENCITY Granted Approval by the FDA

The FDA Granted Orphan Drug Designation to Regenxbio Investigational Gene Therapy Drug RGX-202 for Duchenne Muscular Dystrophy

Let’s Talk About 3 Firms with Important News: Cassava Sciences, Vertex Pharmaceuticals and Gilead Sciences

Arcus Biosciences Stock Price Skyrockets Following Gilead Sciences Decision to Augment Their Partnership